biotechnetworks.bsky.social
@biotechnetworks.bsky.social
12 followers 10 following 1.1K posts
Posts Media Videos Starter Packs
DCBN Trending: Consolidating Novavax transfers Maryland HQ lease to AstraZeneca in $60M deal https://zpr.io/wyXZKPjmF22B
SDBN Trending: Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program https://zpr.io/3CeK2AJ5JQkQ
SDBN Trending: UC San Diego Pharmacy School Names Inaugural Chair of New Department https://zpr.io/ef6SDipXtqGN
SFBN Trending: PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 https://zpr.io/dkPf5Aqvmxu8
SFBN Trending: Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025 https://zpr.io/qc3GJ4RPGaLm
BCBN Trending: Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept Data in Primary Sjögren’s Disease https://zpr.io/JYgWMjRGe27e
BCBN Trending: Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors https://zpr.io/ZDHpjskps8jR
PNBN Trending: Malvern firm selling drug portfolio in potential $105M deal after FDA setback https://zpr.io/F8DuRSYLEgXV
bionetworks Trending: I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025 https://zpr.io/cRBrGzHksDu8
DCBN Trending: Novavax shrinking Montgomery County footprint, transferring manufacturing building to AstraZeneca https://zpr.io/NKkqEj3yMWsN
SDBN Trending: Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine https://zpr.io/uHW5uujvf6ZJ
MWBN Trending: Out of the Darkness Chicagoland Walk and Bank of America Chicago Marathon AFSP Race for Hope Team Raise over $1.8 Million in 2025 https://zpr.io/WgCcMfHnymsg
BCBN Trending: Cambridge biotech launches with Pfizer deal, and other life sciences news https://zpr.io/BtynkYydkKsP
WOBN Trending: Merck, Pfizer, and Astellas’ Keytruda and Padcev Reduce Risk of Death by 50% in Another Massive Showing in Bladder Cancer https://zpr.io/PywpLTdGE9N8
TXBN Trending: Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025 https://zpr.io/VS4yNzUWF4Ly
SFBN Trending: AESOP Technology announces DxPrime is now a qualified solution on Mayo Clinic Platform https://zpr.io/N2FqU7tSczLm
SFBN Trending: Foresight Mental Health Launches Comprehensive Maternal Mental Health Program to Address Critical Gaps in Care https://zpr.io/mLzrEXvEtYds
LABN Trending: Breakthrough Genomics Showcases Largest Interpreted Literature Database and Unveils New AI Capabilities at ASHG 2025 https://zpr.io/GX5R5L9gxmuF
SDBN Trending: Illumina’s Steve Barnard Provides an Update on the Company’s Unfolding Multiomics Strategy https://zpr.io/nscALJr5frPS
WOBN Trending: Alpenglow Teams Up with Virdx to Boost Prostate Cancer Diagnosis with Nvidia, AI Power https://zpr.io/KDwYwajNtXTr
PNBN Trending: Regeneron reaches patent deal with Celltrion over Eylea biosimilar https://zpr.io/hBBRFrNpL9Vp
SDBN Trending: Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity https://zpr.io/y5RHh73pFtbH
BCBN Trending: Eli Lilly doubles Seaport footprint with new lease, taking entire building at 645 Summer St https://zpr.io/x3t9c2X6ZzSE
DCBN Trending: Amalgam Rx’s Medical-Grade AI™ Doubles Digital Health Engagement—Validated in Peer-Reviewed Studies. https://zpr.io/9QAsJDbsjMSm